Patent ID: 9233127
Filing Date: 2016-01-12
CPC Classification: A61K,A61P

Claim Text:
1. A method for enhancing hemopoietic cell engraftment in a subject in need thereof, said method comprising contacting a population of cells comprising hemopoietic cells with an effective amount of at least one agent that enhances engraftment of said hemopoietic cells and administering said population of cells to said subject, wherein said population of cells comprising hemopoietic cells is selected from the group consisting of umbilical cord blood cells, peripheral blood cells, and bone marrow cells, wherein at least one of said at least one agents is complement protein fragment 3a (C3a) or active fragments and homologs thereof, further wherein two populations of umbilical cord blood cells are administered and each of said administered populations comprises at least 1.5×10 7 nucleated cells/kg.